tiprankstipranks
Advertisement
Advertisement
Sionna Therapeutics price target raised to $55 from $44 at Stifel
PremiumThe FlySionna Therapeutics price target raised to $55 from $44 at Stifel
2M ago
Citizens biotechnology analyst holds analyst/industry conference call
Premium
The Fly
Citizens biotechnology analyst holds analyst/industry conference call
2M ago
Yazdi Reiterates Buy on Sionna, Keeps $58 Price Target Ahead of High-Impact 2026 SION-719 Readout
Premium
Ratings
Yazdi Reiterates Buy on Sionna, Keeps $58 Price Target Ahead of High-Impact 2026 SION-719 Readout
2M ago
Three new option listings on March 17th
PremiumThe FlyThree new option listings on March 17th
4M ago
SION Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SION Earnings this Week: How Will it Perform?
4M ago
Sionna Therapeutics price target raised to $50 from $45 at Guggenheim
Premium
The Fly
Sionna Therapeutics price target raised to $50 from $45 at Guggenheim
4M ago
Sionna Therapeutics initiated with an Outperform at Citizens
PremiumThe FlySionna Therapeutics initiated with an Outperform at Citizens
4M ago
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
Premium
Ratings
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
6M ago
Sionna Therapeutics price target raised to $58 from $50 at BTIG
Premium
The Fly
Sionna Therapeutics price target raised to $58 from $50 at BTIG
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100